Shanghai Pharmaceuticals
A leading Chinese pharmaceutical company in R&D, manufacturing, and distribution.
Last updated October 9, 2026
AI crawler reads
4requests
1companies- Anthropic4
- Profile
- 2
- Controversies
- 2
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Shanghai Pharmaceuticals is a leading Chinese pharmaceutical company covering R&D, manufacturing, distribution, and retail, with products including chemical drugs, biologics, and traditional Chinese medicine.
Products and positioning
One of the leading enterprises in China's pharmaceutical industry.
Product categories. chemical drugs · biologics · traditional Chinese medicine · pharmaceutical distribution services
Controversies
2023
Subsidiary fined and disgorged a total of about RMB 462 million for unfair high-price drug sales
In 2023, the Shanghai Municipal Administration for Market Regulation found that Shanghai Pharmaceuticals subsidiary Shanghai No. 1 Biochemical & Pharmaceutical Co. abused its dominant market position by selling polymyxin B sulfate for injection at unfairly high prices. It confiscated about RMB 338 million in illegal gains and imposed a fine of about RMB 124 million. The liable party was that subsidiary and the specified drug.
Recent events
Reported
Shanghai Pharmaceuticals and CanSino Biologics sign strategic cooperation agreement[2]
Shanghai Pharmaceuticals and CanSino Biologics signed a strategic cooperation agreement covering vaccine research and development, production and capacity expansion, materials reserves, and supply-chain development. The agreement also provides for nationwide vaccine storage, distribution, and supply-chain services.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/shanghai-pharmaceuticals · Editorial policy · How profiles are compiled